Drug · DIN 00849405 · Veterinary
POLYFLEX
AMPICILLIN FOR INJECTABLE SUSPENSION USP
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 8, 2021; first marketed December 31, 1990.
- Drug Identification Number (DIN)
- 00849405
- Company (DIN owner)
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Suspension
- Route
- Intramuscular
- Class
- Veterinary
- Record last updated
- September 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMPICILLIN (AMPICILLIN TRIHYDRATE) | 25 G | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 15, 2021: NOC 26072Supplement to a New Drug Submission (SNDS) · Manufacturing Change
- June 8, 2021: NOC 26021New Drug Submission (NDS) · Change in product ownership
- March 23, 2021: NOC 25510Supplement to a New Drug Submission (SNDS) · Addition of analternate drug product manufacturing site, manufacturing change
- June 6, 2019: NOC 22242Supplement to a New Drug Submission (SNDS) · Manufacturing change
- April 13, 2017: NOC 19158Supplement to a New Drug Submission (SNDS) · Addition of manufacturing site
- September 29, 2010: NOC 11766New Drug Submission (NDS) · Change in ownership
- May 19, 2004: NOC 3629New Drug Submission (NDS)
- May 2, 2002: NOC 6107Supplement to a New Drug Submission (SNDS) · Alternate source of active ingredient
- June 1, 1998: NOC 6887New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “polyflex”. A notice may cover another product or only some lots: read it to see what it covers.
- Polyflex powder for suspension; Cracked vialsJune 17, 2026 · Veterinary drugs · Product quality · Type II
Other DINs named POLYFLEX
- DIN 00857629 · Cancelled Post Market